tradingkey.logo

Vistagen Therapeutics Inc

VTGN
0.728USD
+0.015+2.08%
Close 12/24, 16:00ETQuotes delayed by 15 min
28.31MMarket Cap
LossP/E TTM

Vistagen Therapeutics Inc Earnings Date

Period
FY2025 Earnings Date
Revenue(YoY)
486.00K
-54.32%
EPS(YoY)
-1.67
-9.77%
Analyst Rating
STRONG BUY
2025-12-09

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its total revenue reached 486.00K, with a year-on-year change of -54.32%.

What is the Earnings Per Share (EPS) of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.665, with a year-on-year change of -9.77%.

What is the net income of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its net income was -51.42M, with a year-on-year change of -75.12%.

What is the net margin of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its net profit margin was -10579.84%, with a year-on-year change of -283.38%.

What is the gross margin of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its gross margin was 100.00%, with a year-on-year change of --.

What is the debt-to-asset ratio of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.

What is the Return on Equity (ROE) of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -55.68%, with a year-on-year change of -19.83%.

What is the Return on Assets (ROA) of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -49.44%, with a year-on-year change of -21.86%.

What is the operating profit of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its operating profit was -55.97M, with a year-on-year change of -69.51%.

What are the current assets of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its current assets were 82.08M, with a year-on-year change of -31.98%.

What are the total assets of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its total assets of Vistagen Therapeutics Inc were 84.34M, with a year-on-year change of -31.79%.

What are the total liabilities of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its total liabilities of Vistagen Therapeutics Inc were 13.95M, with a year-on-year change of 48.94%.

What is the total equity of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its total equity of Vistagen Therapeutics Inc was 70.39M, with a year-on-year change of -38.41%.

What is the net operating income of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its net operating income of Vistagen Therapeutics Inc was -51.42M, with a year-on-year change of -75.12%.

What is the net investment of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its net investment of Vistagen Therapeutics Inc was -13.15M, with a year-on-year change of -21454.10%.

What is the net financing of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2025 earnings report, its net financing of Vistagen Therapeutics Inc was 3.21M, with a year-on-year change of -97.50%.
KeyAI